ACI-01IAV Health
Is the Investor Acquisition Vehicle operating as a coordinated, governed system capable of supporting sustainable capital formation?
IAV Health concerns the condition, maturity, integration, readiness, and operating effectiveness of the Investor Acquisition Vehicle. It can require evidence across:
- Management
- Accountability
- Investor acquisition
- Investor relations
- Operations
- Handoffs
- Data
- Technology
- Measurement
- Governance
- Relationship continuity
- Evidence quality
A successful capital raise does not independently establish healthy IAV condition. Capital raised is an outcome. IAV Health concerns the capability producing that outcome.
ACI-02Investor Relationships
What is the condition, depth, continuity, preservation, and strategic quality of the qualified investor relationships the organization holds?
A contact record is not automatically a relationship. A meeting is not automatically a durable relationship. A prior investor is not automatically an actively preserved relationship. Supporting evidence may include:
- Qualified Investor Relationships
- Relationship Continuity Condition
- Relationship Depth Indicator
- Relationship Preservation Rate
- Relationship Progression Rate
- Reactivation
- Repeat Investor Participation
- Referral influence
Relationship Health may support this ACI as a diagnostic. Relationship Health is not a separate ACI.
ACI-03Capital Formation
How effectively are appropriate qualified investor relationships and supporting resources progressing toward Recognized Capital Acquired?
- Capital Target
- Recognized Capital Acquired
- Capital Acquisition Velocity
- Capital concentration
- Existing-investor contribution
- Referral-sourced capital
This ACI helps explain both what capital formed, and how it formed. Do not create an artificial universal Capital Formation Composite Score.
ACI-04Capital Efficiency
How effectively is the IAV using organizational resources to produce current capital-formation outcomes while preserving or strengthening future capability?
Capital Efficiency is not simply ROAS, ROI, lowest CPL, or lowest acquisition cost. Leadership may need to consider Marketing Investment, Cost of Acquiring Capital, Capital Acquisition Velocity, and future capability created.
The cheapest activity is not automatically the most capital-efficient system. Do not invent a definitive numerical Capital Efficiency Composite Score.
ACI-05Acquisition Capital
What durable investor-acquisition value and organizational capability is current activity building, preserving, strengthening, or depleting?
- Attention Capital
- Authority Capital
- Brand Capital
- Communication Capital
- Content Capital
- Data Capital
- Educational Capital
- Intellectual Capital
- Intelligence Capital
- Knowledge Capital
- Network Capital
- Relationship Capital
- Reputation Capital
- Trust Capital
These are organizational forms of capability and strategic value within AIAS, not balance-sheet assets with assigned monetary values. Do not create a definitive Acquisition Capital Composite Score. The current raise should leave the organization with more capability than it had before the raise began.
ACI-06Marketing Equity
What durable and reusable value is the organization retaining from Marketing and investor-acquisition activity?
Marketing can create temporary activity. It can also create assets and capabilities that remain useful after an individual campaign ends: presence, authority, audience, content, accumulated data, educational assets, knowledge, reusable infrastructure, brand credibility, market familiarity.
Marketing Equity asks what remains after the campaign ends. Do not invent a definitive numerical Marketing Equity Composite Score.
System view
The six indicators should not be averaged into one convenient number.
Each ACI evaluates a different management condition. Strength in one condition should not automatically erase a material weakness in another. A simple average can create false certainty.
A strong Capital Formation result should not automatically hide deteriorating Investor Relationships. Strong campaign economics should not automatically erase weak Acquisition Capital development. Strong Marketing Equity should not automatically prove overall IAV Health.
- No six-ACI arithmetic average
- No universal ACI score
- No arbitrary weighting
- No arbitrary thresholds
- No decorative gauges
- No green/yellow/red logic without governed criteria
Condition→Direction→Evidence Confidence→Materiality→Risk→Drivers→Exceptions→Score only where validated